Knight Therapeutics Inc. (TSX:GUD)
5.87
+0.07 (1.21%)
Oct 23, 2025, 4:00 PM EDT
Knight Therapeutics Employees
Knight Therapeutics had 745 employees as of December 31, 2024. The number of employees increased by 20 or 2.76% compared to the previous year.
Employees
745
Change (1Y)
20
Growth (1Y)
2.76%
Revenue / Employee
516.19K CAD
Profits / Employee
514.09 CAD
Market Cap
585.11M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 745 | 20 | 2.76% |
| Dec 31, 2023 | 725 | 27 | 3.87% |
| Dec 31, 2022 | 698 | 38 | 5.76% |
| Dec 31, 2021 | 660 | -19 | -2.80% |
| Dec 31, 2020 | 679 | 630 | 1,285.71% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Extendicare | 23,000 |
| Sienna Senior Living | 12,263 |
| dentalcorp Holdings | 10,200 |
| Trulieve Cannabis | 6,000 |
| Curaleaf Holdings | 5,519 |
| Green Thumb Industries | 4,800 |
| Verano Holdings | 3,800 |
| WELL Health Technologies | 1,507 |
Knight Therapeutics News
- 16 days ago - Knight Therapeutics Announces Relaunch of MYFEMBREE® in Canada - GlobeNewsWire
- 16 days ago - Knight Therapeutics Announces Relaunch of ORGOVYX® in Canada - GlobeNewsWire
- 27 days ago - Knight Therapeutics Inc. places No. 384 on The Globe and Mail’s seventh annual ranking of Canada’s Top Growing Companies - Financial Post
- 27 days ago - Knight Therapeutics Inc. places No. 384 on The Globe and Mail's seventh annual ranking of Canada's Top Growing Companies - GlobeNewsWire
- 2 months ago - Knight Therapeutics announces share buyback plan - Seeking Alpha
- 2 months ago - Knight Announces Normal Course Issuer Bid - GlobeNewsWire
- 2 months ago - Knight Therapeutics Inc. (KHTRF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Knight Therapeutics Reports Second Quarter 2025 Results - GlobeNewsWire